Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: February 7, 2023

Meitheal Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for MEITHEAL, and what generic and branded alternatives to MEITHEAL drugs are available?

MEITHEAL has forty-nine approved drugs.

Summary for Meitheal

US Patents:	0
Tradenames:	39
Ingredients:	38
NDAs:	49

Drugs and US Patents for Meitheal

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Meitheal	MITOMYCIN	mitomycin	INJECTABLE;INJECTION	214504-001	Sep 6, 2022	AP	RX	No	No		See Plans and Pricing				See Plans and Pricing
Meitheal	MITOMYCIN	mitomycin	INJECTABLE;INJECTION	214505-002	Sep 8, 2022	AP	RX	No	No		See Plans and Pricing				See Plans and Pricing
Meitheal	PHENYLEPHRINE HYDROCHLORIDE	phenylephrine hydrochloride	SOLUTION;INTRAVENOUS	210334-001	Apr 27, 2018	AP2	RX	No	No		See Plans and Pricing				See Plans and Pricing
Meitheal	LEVOLEUCOVORIN CALCIUM	levoleucovorin calcium	SOLUTION;INTRAVENOUS	211002-002	Aug 16, 2019		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for MEITHEAL drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Injection	250 mcg/0.5 mL, 1 mL PFS	➤ Subscribe	2012-03-30

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Meitheal

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter

McKinsey

Merck

AstraZeneca

Colorcon

Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.